The US Food and Drug Administration plan for regular updates of the COVID-19 vaccines is a good idea, but advisory committee members suggested it also should be flexible.
The agency’s Vaccines and Related Biological Products Advisory Committee voted unanimously, 21-0, on 26 January that the vaccine composition should...







